REQUEST A DEMO
Total
USD $0.00
Search more companies

SciClone Pharmaceuticals (Holdings) Limited (Hong Kong SAR, China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: SciClone Pharmaceuticals (Holdings) Limited Profile Updated: October 24, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

SciClone Pharmaceuticals (Holdings) Limited is a company located in Shanghai, China. The company was incorporated on November 8, 2010, and its registered capital is 50 million yuan. The company was established as a joint-stock company based on the net assets of Wealth Trend Limited, which was audited as of September 30, 2010. The main products and services of SciClone Pharmaceuticals (Holdings) Limited are not mentioned in the source of the summary. The customers and main markets of the company are also not mentioned.

Headquarters
22/F, Central Plaza, 381 Middle Huaihai Road
Shanghai; Shanghai;

Contact Details: Purchase the SciClone Pharmaceuticals (Holdings) Limited report to view the information.

Website: http://www.sciclone.com

Basic Information
Total Employees:
Purchase the SciClone Pharmaceuticals (Holdings) Limited report to view the information.
Outstanding Shares:
Purchase the SciClone Pharmaceuticals (Holdings) Limited report to view the information.
Registered Capital:
Purchase the SciClone Pharmaceuticals (Holdings) Limited report to view the information.
Financial Auditors:
Purchase the SciClone Pharmaceuticals (Holdings) Limited report to view the information.
Incorporation Date:
May 13, 2020
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
President
Purchase this report to view the information.
Chief Financial Officer
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Ownership Details
Purchase this report to view the information.
15.59%
Purchase this report to view the information.
15.36%
Purchase this report to view the information.
15.14%
Purchase this report to view the information.
13.19%
Purchase this report to view the information.
12.37%
Subsidiaries
Sciclone Pharmaceuticals International Ltd (United Kingdom)
100%
Company Performance
Financial values in the chart are available after SciClone Pharmaceuticals (Holdings) Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
14.76%
Total operating revenue
16.28%
Operating profit (EBIT)
27.47%
EBITDA
35.92%
Net Profit (Loss) for the Period
31.16%
Total assets
-7.41%
Total equity
9.12%
Operating Profit Margin (ROS)
3.98%
Net Profit Margin
4.44%
Return on Equity (ROE)
5.77%
Debt to Equity Ratio
-27.49%
Quick Ratio
0.61%
Cash Ratio
0.72%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?